Drug Discovery Laboratories, Sanwa Kagaku Kenkyusho Co., Ltd, Hokusei-cho, Inabe-shi Mie, Japan.
Bioorg Med Chem Lett. 2012 Aug 1;22(15):5123-8. doi: 10.1016/j.bmcl.2012.05.117. Epub 2012 Jun 17.
We disclosed a novel series of G-protein coupled receptor 119 (GPR119) agonists based on a bicyclic amine scaffold. Through the optimization of hit compound 1, we discovered that the basic nitrogen atom of bicyclic amine played an important role in GPR119 agonist activity expression and that an indanone in various bicyclic rings was suitable in this series of compounds. The indanone derivative 2 showed the effect of plasma glucose control in oGTT and scGTT in the rodent model.
我们公开了一系列基于双环胺骨架的新型 G 蛋白偶联受体 119(GPR119)激动剂。通过对先导化合物 1 的优化,我们发现双环胺的碱性氮原子在 GPR119 激动剂活性表达中起着重要作用,而且各种双环环中的茚满酮在这一系列化合物中是合适的。茚满酮衍生物 2 在啮齿动物模型的 oGTT 和 scGTT 中显示出控制血糖的作用。